Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) is a publicly traded Healthcare sector company. As of September 9, 2026, MRVI trades at $6.96 with a market cap of $1.09B and a P/E ratio of -13.59. MRVI moved -2.43% today. Year to date, MRVI is +121.23%; over the trailing twelve months it is +194.67%. Its 52-week range spans $1.67 to $9.42. Analyst consensus is buy with an average price target of $7.25. Rallies surfaces MRVI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for MRVI, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $6.96 |
| Market Cap | $1.09B |
| P/E Ratio | -13.59 |
| EPS | $-0.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.42 |
| 52-Week Low | $1.67 |
| Volume | 379.51K |
| Avg Volume | 0 |
| Revenue (TTM) | $208.78M |
| Net Income | $-136.08M |
| Gross Margin | 34.89% |
3 analysts cover MRVI: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.25.